OAR 333-023-0815: Notification to Patients
Edition: Current OARD snapshotEffective: 2018-05-07Last verified: 2026-09-07
Using language provided by the Authority, a pharmacy shall notify each patient receiving a controlled substance about the Prescription Drug Monitoring Program before or when the controlled substance is dispensed to the patient. The notification shall include that the prescription will be entered into the system.
Official history and status
Statutory/Other Authority: ORS 431A.855
Statutes/Other Implemented: ORS 431A.855
History: PH 209-2018, minor correction filed 05/07/2018, effective 05/07/2018 Renumbered from 410-121-4015, PH 28-2015, f. 12-29-15, cert. ef. 1-1-16 DMAP 6-2011, f. & cert. ef. 5-5-11
This rule cites
No citations extracted.
Cited by
No inbound citations found.
Official source: https://secure.sos.state.or.us/oard/